CINECA IRIS Institutional Research Information System

LAZZARATO, Loretta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.086
EU - Europa 4.032
AS - Asia 3.461
SA - Sud America 508
AF - Africa 67
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 9
Totale 15.199
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.960
SG - Singapore 1.349
CN - Cina 1.288
IT - Italia 945
DE - Germania 778
IE - Irlanda 451
BR - Brasile 429
SE - Svezia 326
UA - Ucraina 238
FI - Finlandia 224
FR - Francia 206
AT - Austria 184
GB - Regno Unito 176
VN - Vietnam 172
KR - Corea 170
PL - Polonia 160
DK - Danimarca 132
IN - India 111
CA - Canada 90
ID - Indonesia 76
JP - Giappone 65
HK - Hong Kong 56
NL - Olanda 56
TR - Turchia 42
RU - Federazione Russa 36
MX - Messico 28
BE - Belgio 19
EC - Ecuador 19
NZ - Nuova Zelanda 19
AR - Argentina 18
UZ - Uzbekistan 18
BD - Bangladesh 17
CH - Svizzera 17
EG - Egitto 17
ES - Italia 17
AU - Australia 16
JO - Giordania 15
SN - Senegal 15
ZA - Sudafrica 14
TW - Taiwan 13
PE - Perù 12
IQ - Iraq 10
LT - Lituania 10
GR - Grecia 8
IR - Iran 8
SK - Slovacchia (Repubblica Slovacca) 8
CO - Colombia 7
CZ - Repubblica Ceca 7
EU - Europa 7
SA - Arabia Saudita 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
CL - Cile 6
TH - Thailandia 6
HU - Ungheria 5
IL - Israele 5
MA - Marocco 5
PY - Paraguay 5
RO - Romania 5
UY - Uruguay 5
BG - Bulgaria 4
NO - Norvegia 4
PH - Filippine 4
PK - Pakistan 4
PT - Portogallo 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
HR - Croazia 3
KE - Kenya 3
MY - Malesia 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
AZ - Azerbaigian 2
BQ - ???statistics.table.value.countryCode.BQ??? 2
CD - Congo 2
CY - Cipro 2
KG - Kirghizistan 2
PA - Panama 2
BB - Barbados 1
BH - Bahrain 1
CI - Costa d'Avorio 1
GE - Georgia 1
GN - Guinea 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NG - Nigeria 1
PS - Palestinian Territory 1
PW - Palau 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 15.199
Salva come PNG Salva come JPEG
Città #
Ann Arbor 698
Singapore 638
Chandler 609
Beijing 584
Ashburn 559
Fairfield 541
Dublin 443
Santa Clara 381
Frankfurt am Main 269
Woodbridge 268
Torino 252
Houston 249
Seattle 212
Wilmington 209
Vienna 172
Cambridge 171
Jacksonville 166
Dallas 155
Pisa 146
Warsaw 146
Dearborn 136
Nyköping 126
Medford 108
Princeton 104
Villeurbanne 104
Columbus 95
Turin 94
Munich 92
Buffalo 82
Hefei 78
Redwood City 77
Jakarta 72
Los Angeles 72
Fremont 60
Seoul 57
Boardman 47
Shanghai 46
Boston 45
Dong Ket 43
Helsinki 40
Milan 40
New York 38
Hong Kong 37
Ho Chi Minh City 36
Nanjing 36
San Diego 35
Turku 35
Guangzhou 34
Nuremberg 34
São Paulo 33
Hangzhou 32
Toronto 31
Council Bluffs 30
Ottawa 27
Redondo Beach 23
Washington 23
Wuhan 22
Bengaluru 20
The Dalles 20
Hanoi 19
Zhengzhou 19
Brussels 18
Norwalk 18
Leinì 17
Naples 17
Phoenix 17
Jinan 16
Auckland 15
Silver Spring 15
Bologna 14
Groningen 14
Amman 13
Pune 13
Rio de Janeiro 13
Siena 13
Tokyo 13
Brooklyn 12
Changsha 12
Guiyang 12
London 12
Mumbai 12
Rome 12
Shenyang 12
Verona 12
Belo Horizonte 11
Falls Church 11
Lappeenranta 11
Mexico City 11
Brasília 10
Chengdu 10
Lima 10
Nürnberg 10
Paris 10
Cairo 9
Curitiba 9
Taipei 9
Ankara 8
Chennai 8
Chicago 8
Florence 8
Totale 9.545
Salva come PNG Salva come JPEG
Nome #
Quinone based nitric oxide donating compounds 648
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance 457
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells 344
Doxorubicin-antioxidant multitarget drugs 325
New furoxan derivatives for the treatment of ocular hypertension 317
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance. 314
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors. 292
A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery 261
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins 248
Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis 233
New nitric oxide or hydrogen sulfide releasing aspirins 227
A rapid screening for cytochromes P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives 217
Combination of PDT and NOPDT with a tailored BODIPY derivative 215
A Nonmetal-Containing Nitric Oxide Donor Activated with Single-Photon Green Light 213
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury 206
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs 202
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis 196
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity 196
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants 193
Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents 189
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug 187
Anti-pseudomonas activity of 3-nitro-4-phenylfuroxan 186
A Potent and Selective P-gp Modulator for Altering Multidrug Resistance Due to Pump Overexpression 180
Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth 179
Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues. 178
Light-Tunable Generation of Singlet Oxygen and Nitric Oxide with a Bichromophoric Molecular Hybrid: a Bimodal Approach to Killing Cancer Cells 178
gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension 176
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization 172
Amphiphilic NO-Donor Antioxidants 172
Structural and biological characterization of new hybrid drugs joining an HDAC inhibitor to different NO-donors 170
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells 165
Aceclofenac-galactose conjugate: design, synthesis, characterization and pharmacological and toxicological evaluations 163
A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion 161
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae 161
Synthesis and biological evaluation of the first example of NO-donor histone deacetylase inhibitor 160
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans 160
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs) 159
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor 159
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity 159
Searching for new NO-donor Aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid 157
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties 154
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light 154
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid (ASA) Prodrugs 154
NO-Donor Melatonin Derivatives: Synthesis And In Vitro Pharmacological Characterization 154
A new class of ibuprofen derivatives with reduced gastrotoxicity 151
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile 147
Multitarget Drugs: Focus on the NO-donor hybrid drugs 145
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties 143
Mitochondrial delivery of phenol substructure triggers mitochondrial depolarization and apoptosis of cancer cells 141
A novel hybrid aspirin-NO releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages 140
Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution 137
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties 134
DNA-targeted NO release photoregulated by green light 132
Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin-Like Molecules that Covalently Inactivate Cyclooxygenase-1 131
EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY. 126
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives 125
Can we exploit β-lactamases intrinsic dynamics for designing more effective inhibitors? 123
Mechanistic insights into cyclooxygenase irreversible inactivation byaspirin 119
BROAD SPECTRUM METALLO beta-LACTAMASES INHIBITORS: NEW TOOLS AGAINST CLINICALLY-RELEVANT CARBAPENEMASES 117
Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin 115
Synthesis and antimalarial activities of some furoxan sulfones and related furazans 113
NO-Donor Cyanines As Potential Anti-Alzheimer Drugs 113
Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage 109
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors 106
A NEW CLASS OF BISPHOSPHONATES WITH NO-DONOR PROPERTIES 103
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. 103
GIFC-2018 - BOOK OF ABSTRACTS 103
Amphiphile NO-donor antioxidants as polivalent drugs 102
Novel water soluble furoxan derivatives having antitumor activity 102
A generator of peroxynitrite activatable with red light 100
Cryo-EM structures of staphylococcal IsdB bound to human hemoglobin reveal the process of heme extraction 92
Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma 92
nitric oxide furoxan derivative compounds endowed with antitumoral activity 90
Furoxan nitric oxide donors disperse Pseudomonas aeruginosa biofilms, accelerate growth, and repress pyoverdine production 87
Nitrooxymethyl substituted analogues of celecoxib as potential antitumoral drugs with reduced cardiotoxicity 85
Enhancing doxorubicin anticancer activity with a novel polymeric platform photoreleasing nitric oxide 85
Novel amphiphilic nitric oxide releasing antioxidants: NMR spectroscopic study of their interaction with biomembrane models 84
NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY 80
Salicilic acid derivatives 79
New class of NO-donor soluble aspirins 78
Structure-Antioxidant Activity Relationships in a Series of NO-Donor Phenols 77
Green Solid Lipid Nanoparticles by Fatty Acid Coacervation: An Innovative Nasal Delivery Tool for Drugs Targeting Cerebrovascular and Neurological Diseases 76
Identification of small molecules affecting the interaction between human hemoglobin and Staphylococcus aureus IsdB hemophore 76
NO donor - melatonins: a new class of potential antiatherosclerosis agents 76
NEW CLASS OF NO-DONORS WITH BONE SELECTIVITY 75
Nitrooxymethyl substituted analogues of Celecoxib and Rofecoxib 75
Use of Enzymatically Activated Carbon Monoxide Donors for Sensitizing Drug-Resistant Tumor Cells 74
Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma 73
Synthesis of NO-Donor Bisphosphonates and Their in Vitro Action on Bone Resorption 73
Galactosylated Prodrugs: A Strategy to Improve the Profile of Nonsteroidal Anti-Inflammatory Drugs 70
Synthesis, chiral HPLC resolution and configuration assignment of 1-phenylglyceryl trinitrate stereomers 69
Tuning NO release of organelle-targeted furoxan derivatives and their cytotoxicity against lung cancer cells 69
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein 68
NO in Viral Infections: Role and Development of Antiviral Therapies 67
NO release regulated by doxorubicin as the green light-harvesting antenna 67
New NO-donor Bisphosphonates 65
Studies of the potential genotoxic effects of furoxans: the case of CAS 1609 and of the water soluble analogue of CHF 2363 65
Cryo-EM undiscloses structural and mechanistic details on iron hijacking by Staphylococcus aureus: An insight into the interaction of IsdB hemophore with human hemoglobin 64
New lipophilic organic nitrates: Candidates for chronic skin disease therapy 64
The Furoxan System: Design of Selective Nitric Oxide (NO) Donor Inhibitors of COX-2 Endowed with Anti-Aggregatory and Vasodilating Activities 63
Totale 14.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.217
article - articoli 0
book - libri 0
conference - conferenze 5.462
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.679
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021925 0 0 0 0 118 82 82 92 174 133 72 172
2021/20221.634 134 91 113 149 91 57 116 107 76 91 349 260
2022/20231.822 173 173 54 160 148 433 229 93 170 71 75 43
2023/20241.046 111 140 64 66 88 173 42 57 21 75 83 126
2024/20252.828 68 191 162 228 511 183 112 128 360 185 289 411
2025/20262.022 482 305 383 689 163 0 0 0 0 0 0 0
Totale 15.549